Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aberle DR, Black WC, Goldin JG et al. Contemporary screening for the detection of lung cancer protocol, May 10, 2002. American College of Radiology Imaging Network (ACRIN #6654) available at http/www.acrin.current-protocols
American Cancer Society (1980) Cancer of the lung. Ca Cancer J Clin 30:189–206
Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342:1878–1886
Black WC (2000) Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. Editorial. J Natl Cancer Inst 92:1–6
Black WC, Haggstrom AD, Welch HG (2002) All-cause mortality in randomized trials of cancer screening. JNCI 94:167–173
Chirikos TN, Hazelton T, Tockman M, Clark R (2002) Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. Chest 121:1507–1514
Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887–1892
Cox DR, Oakes D (1984) Analysis of survival data. Chapman and Hall, London
Earnest F, Swensen SJ, Zink FE (2003) Respecting patient autonomy: screening at CT and informed consent. Radiology 226:633–634
Eddy DM (1989) Screening for lung cancer. Ann Intern Med 111:232–237
Epler GR (1990) Screening for lung cancer. Is it worthwhile? Postgrad Med 87:181–186
Flehinger BJ, Kimmel M (1987) The natural history of lung cancer in a periodically screened population. Biometrics 43:127–144
Flehinger BJ, Kimmel M, Melamed MR (1992) Survival from early lung cancer: Implications for screening. Chest 101:13–18
Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR (1986) Lung cancer screening: the Mayo program. J Occup Med 28:746–750
Fryback DG, Thornbury JR (1991) The efficacy of diagnostic imaging. Med Decis Making 11:88–94
Gorlova OY, Kimmel M, Henschke C (2001) Modeling of long-term screening for lung cancer. Cancer 92:1531–1540
Gøtzsche PC, Olsen O (2000) Is screening for breast cancer with mammography justifiable? Lancet 355:129–134
Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP (1999) Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354:99–105
Henschke CI, Yankelevitz DF, Smith JP, Miettinen OS (2002a) In: DeVita VT, Hellman S, Rosenberg SA (eds) The use of spiral CT in lung cancer screening. Progress in Oncology 2002. Jones and Barlett, Sudbury, Massachusetts
Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS (2002b) CT screening for lung cancer: frequency and significance of part-solid and non-solid nodules. AJR 178:1053–1057
Henschke CI, Wisnivesky JP, Yankelevitz DF, Miettinen OS (2003a) Small stage I cancers of the lung: genuineness and curability. Lung Cancer 39:327–30
Henschke CI, Yankelevitz DF, Kostis WJ (2003) CT screening for lung cancer. Semin Ultrasound CT MRI 24:23–32
Henschke CI, Naidich DP, Yankelevitz DF, McGuinness G, McCauley DI, Smith JP, Libby DM, Pasmantier MW, Koizumi J, Vazquez M, Flieder D, Altorki NK, Miettinen OS (2001) Early Lung Cancer Action project: initial findings from annual repeat screening. Cancer 92:153–159
Henschke CI, Yankelevitz DF, Naidich D, McCauley DI, McGuinness G, Libby DM, Smith JP, Pasmantier MW, Miettinen OS. CT screening for lung cancer: Significance of nodules at baseline according to size. Radiology 2003 in press
Hill AB (1990) Suspended judgment. Memories of the British Streptomycin Trial in Tuberculosis. The first randomized clinical trial. Control Clin Trials 11:77–79
Hillman BJ (1994) Outcomes research and cost-effectiveness analysis for diagnostic imaging. Radiology 193:307–310
I-ELCAP protocol. http://ICScreen.med.cornell.edu
International Early Lung Cancer Action Project. http:// www.IELCAP.org
Inoue K, Sato M, Fujimura S, Sakurada A, Usuda K, Kondo T, Tanita T, Handa M, Saito Y, Sagawa M (1998) Prognostic Assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993. J Thorac Cardiovasc Surg 116:407–411
International Conferences on Screening for Lung Cancer. Consensus statements. http://ICScreen.med.cornell.edu
Kaneko M, Eguchi K, Ohmatsu H, Kakinuma R, Naruke T, Suemasu K, Moriyama N (1996) Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 201:798–802
Kimmel M, Gorlova OY, Henschke CI. Modeling lung cancer screening. In: Quantitative Methods for Cancer and Human Health Risk Assessment, eds: L. Edler and C. Kitsos), Wiley and Sons. 2004 In press
Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR (2003) Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. J Am Med Assoc 289:313–322
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365–1371
Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R, Taylor WF, Prorok PC (2000) Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 92:1308–1316
Medical Research Council (1948) Streptomycin treatment of pulmonary tuberculosis. Br Med J ii:769–782
Miettinen OS (1974) Confounding and effect-modification. Am J Epidemiol 100:350–353
Miettinen OS (1985) Theoretical epidemiology. Wiley, New York
Miettinen OS (2000a) Screening for lung cancer: Can it be cost-effective? Can Med Assoc J 162:1431–1436
Miettinen OS (2000b) Screening for lung cancer. Radiol Clin North Am 38:479–486
Miettinen OS (2001) The modern scientific physician, vol 6. The useful property of a screening regimen. CMAJ 165: 1219–1220
Miettinen OS, Henschke CI, Pasmantier MW, Smith JP, Libby DM, Yankelevitz DF (2002a) Mammographic screening: no reliable supporting evidence? Lancet 359:404–405
Miettinen OS, Henschke CI, Pasmantier MW, Smith JP, Libby DM, Yankelevitz DF (2002b) Mammographic screening: no reliable supporting evidence? http://www.lancet.com
Miettinen OS, Yankelevitz DF, Henschke CI (2003) Evaluation of screening for a cancer: annotated catechism of the Gold Standard creed. J Eval Clin Pract 9:145–150
Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717
National Cancer Institute (2000) Screening. Cancer control objectives for the nation: 1985–2000. Division of Cancer Prevention and Control, National Cancer Institute, Green-wald P, Sondik EJ (eds), Monograph, Chap. 3, pp 27–32
National Lung Screening Trial. http://www.nci.nih.gov/nlst/
Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM (1992) Screening sigmoidoscopy and colorectal cancermortality. J Natl Cancer Inst 84:1572–1575
New York Early Lung Cancer Action Project. http://www.NYELCAP.org
Olsen O, Gotzsche PC (2001) Cochrane review of screening for breast cancer with mammography. Lancet 358:1340–1342
Parkin DM, Moss SM (2000) Lung cancer screening: improved survival but no reduction in deaths — the role of “overdiagnosis”. Cancer 89:2369–2376
Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial(PLCO). http://www.cancer.gov/prevention/plco
Sobue T (2000) A case-control study for evaluating lung cancer screening in Japan. Cancer 89(Suppl 11):2392–2396
Sobue T, Suzuki T, Naruke T (1992a) A case-control study for evaluating lung-cancer screening in Japan. Japanese Lung-Cancer-Screening Research Group. Int J Cancer 50: 230–237
Sobue T, Suzuki R, Matsuda M, Kuroishi T, Ikeda S, Naruke T(1992b) Survival for clinical stage I lung cancer not surgically treated. Cancer 69:685–692
Sone S, Takashima S, Li F et al. (1998) Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 351:1242–1245
Swensen SJ (2002) CT screening for lung cancer. Am J Roent-genol 179:833–836
ABIM Foundation. American Board of Internal Medicine; ACP-ASIM Foundation. American College of Physicians-American Society of Internal Medicine; European Federation of Internal Medicine (2002) Medical professionalism in the new millenium: a physician charter. Ann Intern Med 136:243–246
U.S. Preventive Services Task Force (1989) Guide to clinical preventive services. Screening for lung cancer. U.S. Preventive Services Task Force, Washington, D.C., pp 45–47
Vazquez M, Flieder D, Travis W, Carter D, Yankelevitz D, Miet-tinen OS, Henschke CI (2002a) Early Lung Cancer Action Project Pathology Protocol. Lung Cancer
Vazquez M, Flieder D, Travis W, Carter D, Yankelevitz D, Miettinen OSM, Henschke CI (2002b) Early Lung Cancer Action Project Pathology Protocol. http:// ICScreen.med.cornell.edu
Wisnivesky JP, Mushlin A, Sicherman N, Henschke CI (2002) Cost-effectiveness of baseline low-dose CT screening for lung cancer: preliminary results. Chest 2003; 124:614–621
Yankelevitz DF, Kostis WJ, Henschke CI, Heelan RT, Libby DM, Pasmantier MW, Smith JP (2003) Overdiagnosis in chest radiographic screening for lung cancer: frequency. Cancer 97:1271–1275
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Henschke, C.I., Yankelevitz, D.E., Kostis, W. (2006). CT Screening for Lung Cancer. In: Joseph Schoepf, U. (eds) Multidetector-Row CT of the Thorax. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30006-6_9
Download citation
DOI: https://doi.org/10.1007/3-540-30006-6_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-26247-3
Online ISBN: 978-3-540-30006-9
eBook Packages: Springer Book Archive